Hermetica Superfood Encyclopedia
The Short Answer
Maitake 'Hen of the Woods' (Grifola frondosa) contains a bioactive beta-glucan polysaccharide called D-fraction, which activates macrophages, natural killer cells, and T-cells through pattern recognition receptors such as Dectin-1. This immune modulation forms the basis for its studied antitumor and immunosupportive properties in preliminary clinical research.
CategoryCultivar Variants
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary Keywordmaitake mushroom benefits
Maitake 'Hen of the Woods' (Grifola frondosa 'Hen of the Woods') — botanical close-up
Health Benefits
Origin & History
Natural habitat
Maitake 'Hen of the Woods' (Grifola frondosa) is a polypore mushroom native to China, Europe, and North America that grows at the base of old oaks or maples. This edible fungus is consumed as food in Asia and used medicinally, with bioactive extracts typically obtained via hot water extraction from the fruiting body, yielding polysaccharides as the primary chemical class.
“Maitake has centuries of use in traditional Asian medicine, particularly in Japan, as an immunostimulant for immune enhancement, diabetes, hypertension, and cancer prevention/treatment. It gained medicinal popularity in Japan for immune support alongside its role as an edible delicacy.”Traditional Medicine
Scientific Research
Human clinical evidence remains limited with no large RCTs or meta-analyses identified. A small noncontrolled cancer study reported tumor regression in half of subjects, while an open-label study of 35 HIV patients taking 250mg daily for 12 months showed increased CD4+ counts in 20 patients. No PubMed PMIDs were provided in the research sources.
Preparation & Dosage
Traditional preparation
Clinically studied dosage: 250 mg dried maitake powder daily (combined with 5 mg vitamin C) for 12 months in HIV patients. Standardized extract dosages for D-fraction or MD-fraction have not been established in human trials. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Per 100g fresh weight: Calories ~31 kcal, Protein ~1.9g (containing all essential amino acids including lysine and leucine), Carbohydrates ~6.9g, Dietary Fiber ~2.7g (predominantly beta-glucans, specifically (1→3)(1→6)-beta-D-glucans at approximately 15-30% of dry weight, notably the D-fraction/MD-fraction polysaccharides), Fat ~0.2g. Water content ~90%. Key micronutrients: Potassium ~204mg/100g, Phosphorus ~74mg/100g, Magnesium ~10mg/100g, Copper ~0.3mg/100g (notable concentration supporting enzymatic function), Zinc ~0.9mg/100g, Selenium ~2.2mcg/100g. Vitamins: Niacin (B3) ~6.6mg/100g (significant contributor to daily intake), Riboflavin (B2) ~0.24mg/100g, Pantothenic acid (B5) ~0.28mg/100g, Vitamin D2 (ergocalciferol) ~28 IU/100g when UV-exposed (dramatically increases with sun/UV exposure to potentially 400+ IU). Bioactive compounds: Grifolan (branched beta-glucan), ergosterol ~4.5mg/g dry weight (provitamin D2 precursor), ergothioneine (antioxidant amino acid) ~0.4mg/g dry weight, triterpenes including grifolic acid. Bioavailability notes: Beta-glucan bioavailability enhanced by cooking/hot water extraction; ergothioneine is highly bioavailable in humans via specific transporter OCTN1; Vitamin D2 bioavailability is approximately 70-80% relative to D3.
How It Works
Mechanism of Action
Maitake D-fraction, a proteoglucan beta-1,3/1,6-glucan, binds to Dectin-1 and complement receptor CR3 (CD11b/CD18) on macrophages and dendritic cells, triggering NF-κB signaling and upregulating pro-inflammatory cytokines including TNF-α, IL-12, and IL-1β. This cascade activates NK cells and cytotoxic T-lymphocytes, enhancing cell-mediated immune surveillance. Additionally, D-fraction has demonstrated inhibition of tumor cell proliferation via induction of apoptosis through caspase-3 activation in in vitro models.
Clinical Evidence
A small open-label study in 35 HIV-positive patients found that oral maitake D-fraction supplementation increased CD4+ T-cell counts in approximately 57% of participants, though the lack of a control group severely limits interpretation. A separate noncontrolled observational study reported tumor regression or subjective symptom improvement in roughly 50% of cancer patients using D-fraction as an adjunct to chemotherapy. A phase I/II trial examining maitake whole extract in postmenopausal breast cancer patients (n=29) demonstrated measurable immunological stimulation at doses of 0.1–5 mg/kg, though clinical outcomes were not the primary endpoint. Overall, the evidence base consists largely of small, nonrandomized, or uncontrolled studies, making definitive efficacy conclusions premature.
Safety & Interactions
Maitake is generally well tolerated; reported adverse effects are mild and include gastrointestinal upset such as bloating and loose stools, particularly at higher doses. Because D-fraction can stimulate immune activity, individuals with autoimmune conditions (e.g., lupus, multiple sclerosis, rheumatoid arthritis) or those on immunosuppressant drugs such as cyclosporine or tacrolimus should consult a physician before use. Maitake may have additive hypoglycemic effects when combined with insulin or oral antidiabetic agents such as metformin, warranting blood glucose monitoring. Safety data in pregnancy and lactation are insufficient, so use is not recommended during these periods.
Synergy Stack
Hermetica Formulation Heuristic
Featured in
Eternity
Functional mushroom gummies — Lion's Mane, Reishi, Cordyceps, Chaga & Maitake.
Shop Now →
Frequently Asked Questions
What is maitake D-fraction and what does it do?
Maitake D-fraction is a purified proteoglucan extract composed primarily of beta-1,3/1,6-glucans isolated from Grifola frondosa. It activates immune cells—particularly macrophages and NK cells—by binding to Dectin-1 receptors, which triggers cytokine release including IL-12 and TNF-α, enhancing the body's cell-mediated immune response.
Can maitake mushroom help with cancer?
Preliminary evidence from a small noncontrolled study suggests maitake D-fraction may support tumor regression or symptom improvement in some cancer patients when used alongside conventional therapy, with roughly 50% of participants showing a positive response. However, no large randomized controlled trials have confirmed antitumor efficacy in humans, so maitake should not replace standard cancer treatment.
What is the recommended dosage of maitake D-fraction supplement?
Clinical studies have used doses ranging from 0.1 to 5 mg/kg body weight per day for purified D-fraction extract, while whole maitake powder doses in research contexts have ranged from 500 mg to 4 g daily. No universally established therapeutic dose exists, and dosing should be guided by a healthcare provider given the limited standardization across commercial products.
Does maitake mushroom interact with any medications?
Maitake may potentiate the effects of antidiabetic medications including insulin and metformin by independently lowering blood glucose through enhanced insulin sensitivity, increasing hypoglycemia risk. Its immune-stimulating activity via D-fraction may also counteract immunosuppressant drugs like cyclosporine or tacrolimus, so concurrent use requires medical supervision.
How is Hen of the Woods maitake different from other maitake varieties?
The 'Hen of the Woods' designation refers to the wild-type or standard Grifola frondosa strain, which is the most extensively studied form for its D-fraction and MD-fraction beta-glucan content. Some cultivated maitake strains have been selectively developed for higher beta-glucan concentrations, but the Hen of the Woods form remains the reference variety used in most immunological and antitumor research.
What does the research show about maitake Hen of the Woods for immune support in HIV patients?
A small open-label study of 35 HIV patients found that maitake supplementation was associated with increased CD4+ cell counts in 20 participants, suggesting potential immune-supporting benefits. However, this evidence is preliminary and based on a non-controlled study design, so larger, well-designed clinical trials are needed to confirm these findings and establish clinical significance. Current research does not establish maitake as a replacement for antiretroviral therapy or standard HIV treatment protocols.
Is maitake Hen of the Woods safe for people taking blood sugar medications or insulin?
Maitake mushroom has demonstrated hypoglycemic activity in preliminary studies with type 2 diabetes patients, meaning it may lower blood sugar levels. If you are taking diabetes medications or insulin, consult your healthcare provider before adding maitake supplementation, as combining it with blood sugar-lowering drugs could increase the risk of hypoglycemia. Your doctor may need to monitor your blood glucose levels or adjust medication dosages.
What is the current strength of evidence for maitake Hen of the Woods' antitumor effects?
A non-controlled study reported tumor regression or symptom improvement in approximately half of cancer patients who received maitake supplementation, but this represents very preliminary evidence with significant methodological limitations. The lack of control groups, randomization, and blinding in these studies means the results cannot be considered conclusive or clinically validated. Maitake should not be used as a primary cancer treatment and should only be considered as a complementary approach under medical supervision.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w maitake-hen-of-the-woods curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
